Natera Inc at Canaccord Genuity Growth Conference Transcript
All right. Hi, everyone. Welcome to the Canaccord Genuity Global Growth Conference. I'm Kyle Mikson. I cover Life Sciences and Diagnostics for Canaccord. Pleased to present this fireside chat with Natera here with us. Natera is a leader in cell-free DNA based testing across women's health, oncology and organ health. With us from the company, we have Mike Brophy, CFO. Thanks, Mike, for joining us.
Yes. Thanks for having me.
Questions & Answers
Good to have you. So I think -- so last Thursday, you reported the second quarter results beat consensus by like $20 million on the top line, strong gross margin, broad-based growth. Just talk about like what kind of turned out in terms of volume and ASP dynamics, too?
Yes. I mean, yes, thanks, and
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
